In a multi-center clinical trial, Macroplastique demonstrated excellent clinical efficacy.
PATIENT OUTCOMES WITH MACROPLASTIQUE (1)
- At 12 Months
- 62% of patients had an improvement ≥ 1 Stamey Grade*
- 37% of patients were dry*
- Physicians considered 80% of the patients dry or markedly improved**
- 60% improvement from baseline in Incontinence Quality of Life surveys (IQOL)**
- At 24 Months
- 75% of patients had an improvement ≥ 1 Stamey Grade***
- 33% of patients were dry***
- No serious treatment-related adverse events associated with Macroplastique (1)
1. Ghoniem, G., Corcos, J., Comiter, C., Bernhard, P., Westney, O.L. & Herschorn, S. (2009). Cross-linked polydimethysiloxane injection for female stress urinary incontinence: Results of a multicenter, randomized, controlled, single-blind study. J Urol, 181, 204-210
*122 patients received Macroplastique treatment. Subjects who were lost to follow-up or withdrawn are considered failures.
** Of 102 subjects attending 12 month follow-up.
*** Of 84 subjects attending 24 month follow-up.In a multi-center clinical trial, Macroplastique demonstrated excellent clinical efficacy. ”
MPQ-2.5 Macroplastique Implants, One 2.5 ml unit
AD-US Reusable Administration Device, includes syringe adapter
MRN-420 Rigid Endoscopic Needle 3.8 Fr. shaft x 14.5” (370 mm) long with 20 gauge tip x 0.54” (14 mm) long
MRN-518 Rigid Endoscopic Needle 5 Fr. shaft x 15” (380 mm) long with 18 gauge tip x 0.54” (14 mm) long
Reviews
There are no reviews yet.